SARS-CoV-2-IN-45

SARS-CoV-2-IN-45

• UNSPSC Description: SARS-CoV-2-IN-45 (Compound 8p) is a SARS-CoV-2 inhibitor. SARS-CoV-2-IN-45 inhibits SARS-CoV-2 replication in Calu-3 cell with an EC50 of 0.5 μM, and has no evident cytotoxic effect[1].
• Target Antigen: SARS-CoV
• Type: Reference compound
• Related Pathways: Anti-infection
• Applications: COVID-19-anti-virus
• Field of Research: Infection
• Assay Protocol: https://www.medchemexpress.com/sars-cov-2-in-45.html
• Solubility: 10 mM in DMSO
• Smiles: O=C1C2=CC=C(OCOC)C=C2O/C1=C\C3=CC(OCOC)=C(OC)C=C3
• Molecular Weight: 372.37
• References & Citations: [1]Caleffi GS, et al. Aurones: A Promising Scaffold to Inhibit SARS-CoV-2 Replication. J Nat Prod. 2023 Jun 23;86(6):1536-1549.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported